{"url":"https://lda.senate.gov/api/v1/filings/bc6ae490-c2bb-4d0e-a2f2-40154e690f9f/","filing_uuid":"bc6ae490-c2bb-4d0e-a2f2-40154e690f9f","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/bc6ae490-c2bb-4d0e-a2f2-40154e690f9f/print/","filing_document_content_type":"text/html","income":null,"expenses":"180000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Cate McCanless","dt_posted":"2026-04-14T10:30:49-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"630 W Germantown Pike","registrant_address_2":"Suite 215","registrant_different_address":false,"registrant_city":"Plymouth Meeting","registrant_state":"PA","registrant_zip":"19462","registrant":{"id":401105020,"url":"https://lda.senate.gov/api/v1/registrants/401105020/","house_registrant_id":null,"name":"HARMONY BIOSCIENCES","description":"pharmaceuticals","address_1":"630 W Germantown pike","address_2":"Suite 215","address_3":null,"address_4":null,"city":"plymouth meeting","state":"PA","state_display":"Pennsylvania","zip":"19462","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CATE MCCANLESS","contact_telephone":"+1 202-420-7888","dt_updated":"2026-07-30T13:20:38.186535-04:00"},"client":{"id":203037,"url":"https://lda.senate.gov/api/v1/clients/203037/","client_id":12,"name":"HARMONY BIOSCIENCES","general_description":"pharmaceuticals","client_government_entity":false,"client_self_select":true,"state":"PA","state_display":"Pennsylvania","country":"US","country_display":"United States of America","ppb_state":"PA","ppb_state_display":"Pennsylvania","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-01-03"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Cameron's Law (HR 1414) EPIC Act (HR 1492/S 832) HR 1672 Maintaining Investments in New Innovation Act Issues related to protecting patient access to medicines Issues related to protecting orphan drug policies Issues related to most-favored-nation policies","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":146555,"prefix":"ms","prefix_display":"MS.","first_name":"SUSANNA","nickname":null,"middle_name":"AGUIRRE","last_name":"HASTINGS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69985,"prefix":null,"prefix_display":null,"first_name":"CATE","nickname":null,"middle_name":null,"last_name":"MCCANLESS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}